£2.0M
Longwall Venture Partners led the investment round, which will fund clinical trials and commercial development.
U
UroSens
UroSens develops diagnostic immunoassays to detect prostate and bladder cancer.
United Kingdom—Founded 2007
£2.0MTotal raised
UroSens develops proprietary diagnostic immunoassays using urine samples for the detection of prostate and bladder cancer.
Categories
Team
IC
Ian Campbell
CEO